Rebecca joined Drug Discovery News as an Intern in 2023. She is a PhD candidate at University of Southern California where she studies molecular mechanisms of synaptic plasticity in fruit flies. As an intern, she writes about brain function and health from early development to advanced age. When not in the lab or writing, she can be found hiking in the Los Angeles mountains with her dog.
Chemotherapy patients have reported cognitive impairments known as “chemobrain.” Now, researchers are closer to finding its cause and a potential treatment.
By masking ketamine from placebo for the first time, researchers reveal the importance of accounting for expectancy in trials testing psychoactive drugs.
Researchers identified schizophrenia risk genes that mediate placental, rather than brain, function, revealing new insight into the disease’s developmental origins.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.